CDC began requiring all air passengers two years and older originating from the People’s Republic of China (PRC) to show proof of negative COVID-19 test results to the airline upon departure from PRC. Accepted tests include PCR tests or antigen self-tests administered and monitored by a telehealth service or a licensed provider and authorized by the U.S. Food and Drug Administration or a relevant national authority.
CDC has also expanded the Traveler-based Genomic Surveillance program (TGS), a voluntary program that serves as an early warning system to detect and characterize new and rare variants of the virus that causes COVID-19. The program now includes airports in Los Angeles and Seattle, bringing the total number of airports to seven.
CDC is taking this action to slow the spread of COVID-19 in the United States during the surge in COVID-19 cases in the PRC. This new testing policy, along with the TGS expansion, is intended to help to protect travelers and the health and safety of American communities. CDC will continue to monitor the situation, adjust its approach as needed and provide timely updates as needed.
For more information, view the full press release at CDC Announces Negative COVID-19 Test Requirement from Air Passengers Entering the United States from the People’s Republic of China.